Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E8CI
|
||||
Former ID |
DAP001065
|
||||
Drug Name |
Triprolidine
|
||||
Synonyms |
Actidil; Actidilat; Entra; Histafed; Myidyl; Tripolidina; Triprolidin; Triprolidinum; Venen; Triprolidine HCL; Triprolidine Monohydrochloride; Triprolidine hydrochloride; Triprolidine hydrochloride anhydrous; T 6764; Actidil (TN); Actifed (TN); Myidil (TN); Pro-Actidil; Pro-Entra; Tripolidina [INN-Spanish]; Triprolidine (INN); Triprolidine Hydrochloride (anhydrous); Triprolidine Monohydrochloride, Monohydrate; Triprolidine [INN:BAN]; Triprolidinum [INN-Latin]; Venen (TN); Trans-2-(3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)pyridine; Trans-2-(3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)pyridine monohydrochloride; Trans-1-(2-Pyridyl)-3-pyrrolidino-1-p-tolylprop-1-ene; Trans-1-(4-Methylphenyl)-1-(2-pyridyl)-3-pyrrolidinoprop-1-ene;Pyridine, 2-(3-(1-pyrrolidinyl)-1-p-tolylpropenyl)-, monohydrochloride, monohydrate, stereoisomer; Pyridine, 2-((1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-, monohydrochloride; Pyridine, 2-((1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl)-, hydrochloride (1:1); (E)-2-(1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)pyridine; (E)-2-[3-(1-Pyrrolidinyl)-1-p-tolylpropenyl]pyridine hydrochloride; 2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ium-1-ylprop-1-enyl]pyridine chloride; 2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridine; 2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridine hydrochloride
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antiallergic Agents
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H22N2
|
||||
InChI |
InChI=1S/C19H22N2/c1-16-7-9-17(10-8-16)18(19-6-2-3-12-20-19)11-15-21-13-4-5-14-21/h2-3,6-12H,4-5,13-15H2,1H3/b18-11+
|
||||
InChIKey |
CBEQULMOCCWAQT-WOJGMQOQSA-N
|
||||
CAS Number |
CAS 486-12-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
7980840, 8077587, 11038508, 14897473, 17448291, 26751829, 39315888, 46505403, 47291040, 47440150, 47736373, 47736374, 47885310, 47885311, 48110356, 48334387, 49698410, 49855442, 50104523, 50104524, 50104525, 57309729, 75497893, 85209605, 85788432, 90341007, 92308937, 93166727, 96025331, 103223987, 104133962, 113857221, 124610340, 124886935, 124886936, 134338323, 134975511, 135651281, 137002512, 138314072, 140229550, 144204470, 160963773, 170464931, 172820007, 175267951, 176483998, 179113821, 181753769, 181855806
|
||||
SuperDrug ATC ID |
R06AX07
|
||||
SuperDrug CAS ID |
cas=000486124
|
||||
Target and Pathway | |||||
Target(s) | Histamine H1 receptor | Target Info | Antagonist | [536896] | |
PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
References | |||||
Ref 536361 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. | ||||
Ref 538740 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1228). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.